Cardiovascular Imaging Equipment Market is Increasing at a CAGR of 6.13% during the Study Period from 2021 to 2026, States DelveInsight

LAS VEGAS, Dec. 8, 2021 /PRNewswire/ -- DelveInsight published the latest report, "Cardiovascular Imaging Equipment Market & Competitive Landscape," which provides an in-depth market understanding of Cardiovascular Imaging Equipment that will further benefit the competitors or stakeholders operating in the Cardiovascular Imaging Equipment arena. 

Recent Developmental Activities in Cardiovascular Imaging Equipment Market:

• In August 2021, Royal Philips announced the launch of its digital experience during the virtual European Society of Cardiology (ESC) 2021 Congress. It will highlight its recent suite of solutions to enhance outcomes for cardiovascular disease patients by allowing fast, confident diagnosis, and efficient, effective treatments.
• In May 2021, Abbott received European CE marks for its new interventional imaging platform powered by Ultreon 1.0 Software.
• In January 2021, Ultromics received FDA clearance for EchoGo Pro, a first-of-kind solution to help diagnose Coronary artery disease (CAD).

Interested in knowing how the Cardiovascular Imaging Equipment Market will be growing by 2026? Click to get a snapshot of Cardiovascular Imaging Equipment Market Analysis

Cardiovascular Imaging Equipment Overview 

Non-invasive imaging of the heart with the help of ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or nuclear medicine (NM) imaging with PET or SPECT is referred to as Cardiac imaging. Different types of Echocardiograms available are Transthoracic echocardiogram (TTE), Stress echocardiogram, Doppler echocardiogram, and Transesophageal echocardiogram (TEE). 

Cardiac MRI is the existing standard for quantitation of cardiac chambers and ejection fraction of both right and left ventricles. These imaging methods can be considered important for diagnosing coronary heart disease, heart failure or valve problems, damage caused by a heart attack, congenital heart defects, pericarditis, and cardiac tumors, among others. 

The shift towards personalized medicine will also boost the market for cardiovascular imaging equipment, as it allows more precise and advanced quantification of structural and functional changes due to cardiovascular disorders. A cardiac CT can diagnose narrowed or blocked areas of a blood vessel and also display whether there is a bulge (aneurysm) or a buildup of fatty material (plaque) in blood vessels.

Geography-Wise Cardiovascular Imaging Equipment Market Analysis 

Geographically, the global Cardiovascular Imaging Equipment market is investigated for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the global market and is anticipated to remain constant during the forecast period. Nevertheless, the supremacy of North America will be evidently challenged by the Asia-Pacific market. This is because of the growing need due to the growing number of surgeries, and requirement for advanced technologies in Cardiovascular Imaging Equipment in the region. 

To know more why North America is leading the market growth in the Cardiovascular Imaging Equipment market, get a snapshot of Cardiovascular Imaging Equipment market insight report 

Moreover, due to the increase in the prevalence of cardiovascular disorders (CVD) and the presence of key players in Asia-Pacific regions, there is a growing need observed for Cardiovascular Imaging Equipment in these regions, thereby positively influencing the overall Cardiovascular Imaging Equipment market. 

Covid-19 Impact on Cardiovascular Imaging Equipment Market

The demand for Cardiovascular Imaging Equipment is hampered by the COVID-19 pandemic outbreak. The government imposed lockdowns to stop the spread of the virus. Since the situation of COVID-19 pandemic, several forms of elective procedures were temporarily halted in contrast to the COVID-19 affected patients, which were given supreme priority. This resulted in a decrease in the need for cardiovascular imaging equipment. The decreasing number of cases, increasing vaccination number, and relief in lockdowns is expected to boost the demand for cardiovascular imaging equipment.

The demand for MRI and molecular imaging equipment has decreased during the pandemic and market players such as Philips, GE, and Siemens, observed a decline in demand for these modalities during Q1 2020. However, the reopening of services in most of the countries has led to the restoration of these examinations performed during Q2 2020.

However, post-COVID-19 the healthcare system is trying to get normalcy due to the resumed patent visits, the opening of manufacturing facilities, leverage given in terms of lockdown restrictions among others. Apart from all these factors due to an increase in the recent approvals of cardiovascular imaging, the increase in research and development of technologically advanced cardiovascular imaging in COVID-19 patients and the rise in mergers and acquisitions between the key players active in this arena leading to a growth in the Cardiovascular Imaging Equipment market during the forecast period.

To discuss more the short/long-term impact of COVID-19 get a snapshot of the Cardiovascular Imaging Equipment Market Report 

Cardiovascular Imaging Equipment Market Segmentation

• By Type of Devices
• Echocardiography
• Angiography
• Nuclear Cardiac Imaging
• Computed Tomography
• Cardiac Positron Emission Tomography (Cardiac PET)
• Cardiac Magnetic Resonance Imaging (Cardiac MRI)
• By End-User
• Hospitals
• Specialty Clinics
• Diagnostic Imaging
• Others
• By Geography
• North America
• Europe
• Asia-Pacific
• Rest of World

Cardiovascular Imaging Equipment Market Segment Analysis 

Echocardiography continues to be the main tool in the diagnosis and monitoring of heart diseases because of its benefits. Moreover, it is relatively cheaper, quicker, and has fewer severe effects. Recently, the fusion of different imaging modalities is garnering popularity for cardiovascular interventions, as it generates high-quality images facilitating the real-time monitoring in the operation theatre. 

MRI is likely to show the lucrative growth during the forecast period, since it does not utilize ionizing radiation that makes it a preferred choice for the diagnosis of children and pregnant women. Moreover, advancements in MRI have made it useful for monitoring myocardial and valvular functions as well as for the diagnosis of complex Congenital Heart Disease (CHDs).

Cardiovascular Imaging Equipment Market Scope

• Study Period: 2018-2026
• Key Companies: Toshiba, GE Healthcare, Siemens Healthcare, Philips Healthcare, Epsilon Imaging, and others.
• Segmentation: By Type of Devices,  By End-User, and By Geography
• Geography Covered: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)

Table of Contents 

Related Reports

• Cardiac Monitoring Devices Market and Competitive Landscape 

DelveInsight's 'Cardiac Monitoring Devices -Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Cardiac Monitoring Devices and Competitive Landscape analysis. Key players involved in this market are Medtronic, Boston Scientific, Abbott Laboratories, GE Healthcare, BIOTRONIK,  MicroPort Scientific Corporation, Hill-Rom Holdings, and others.

• Implantable Cardiac Monitors Market and Competitive Landscape 

DelveInsight's Implantable Cardiac Monitors Market Insights, Competitive Landscape, and Market Forecast-2026 report deliver an in-depth understanding of Implantable Cardiac Monitors and Competitive Landscape analysis. Key players involved in this market are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Phoenix Heart Center, and others.

• Ambulatory Arrhythmia Monitoring Devices Market and Competitive Landscape

DelveInsight's Ambulatory Arrhythmia Monitoring Devices Market Insights, Competitive Landscape, and Market Forecast-2030 report deliver an in-depth understanding of Cardiovascular Drugs and Competitive Landscape analysis. Key players involved in this market are Biotronik, Abbott Laboratories, Medtronic plc, GE Healthcare, BioTelemetry, Inc, Applied Cardiac Systems, Inc. and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Business Consulting Services with a credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach. 

Contact Us:

Shruti Thakur
[email protected]   
+1(919)321-6187
www.delveinsight.com

SOURCE DelveInsight Business Research, LLP